Michelle L. Basil, EVP and General Counsel at HAEMONETICS CORP (HAE), sold 2,832 shares at $96.14 ($272K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($272k) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.49 | 416 | $40K | 14.8% |
| 2 | $94.80 | 446 | $42K | 15.6% |
| 3 | $96.14 | 985 | $95K | 34.8% |
| 4 | $96.14 | 985 | $95K | 34.8% |
| Total | $95.98 avg | 2,832 | $272K | 100% |
| Filing → |
| HAE | SELL | 2022-10-26 | $14K | — | Filing → |
| HAE | SELL | 2022-09-21 | $1.8M | — | Filing → |
| HAE | SELL | 2022-09-19 | $5.3M | — | Filing → |